Ignore noise on the street, stick to basics: 5 stocks from different sectors with an upside potential of up to 38%The markets are volatile with a bearish bias, and the Nifty and Sensex are bearing the brunt. A closer look, however, reveals that, even in...
10 Oct, 2024, 05.00 AM IST
Indian Pharma exports: 'USD 10 billion opportunity up for grabs in off patent drug market by 2029'A senior official of the Pharmexcil said drugs such as Merck's Pembrolizumab (Keytruda) whose revenue were at USD 25 billion and Bristol-My...
27 Jun, 2024, 07.59 PM IST
Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
04 Jan, 2024, 02.09 PM IST
These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%In the last few weeks, the range in which the nifty had been moving has become broader as the volatility has increased both due to internat...
14 Nov, 2023, 11.46 AM IST
These largecaps have ‘strong buy’ & ‘buy’ recos and upside scope of over 20%As the market moves from clearly bullish mode to volatile mode with a bearish bias, there will be readjustment in valuation across markets....
07 Nov, 2023, 01.02 PM IST
These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%While the correction has been going on in the market since the middle of July, it is only on days like Monday where everyone on the street ...
25 Oct, 2023, 11.46 AM IST
Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
01 Sep, 2023, 01.34 PM IST
Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
10 May, 2023, 01.13 PM IST
These largecaps have ‘Strong Buy’ & ‘Buy’ reco and upside potential of more than 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...
02 May, 2023, 01.12 PM IST
Stocks in news: Delhivery, Zydus Life, Paytm, SBI, NTPC, RILJapanese multinational conglomerate Softbank Group is looking to sell shares worth Rs 600 crore in Delhivery through block deals on Wednesd...
01 Mar, 2023, 07.07 AM IST
Zydus Lifesciences gets USFDA nod to market generic drugZydus Lifesciences on Tuesday said it has received approval from the US health regulator to market a generic medication to prevent and trea...
28 Feb, 2023, 07.33 PM IST
Should you stick to largecaps amid volatile Nifty? These 4 stocks have up to 30% upside scopeAs volatility increases, the focus in the market is shifting to stocks which are considered as relatively defensive. These stocks tend to f...
09 Feb, 2023, 05.54 PM IST
A consistent wealth creator among 11 stocks that have an upside potential of over 25%As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...
17 Jan, 2023, 11.25 AM IST
DDMA asks pharmacies to display available stock, cost of COVID-19 drugs prominentlyThe drugs are Ivermectin tablets, Doxycyclin tablets/capsule, Methyl Prednisolone tablets and injections, Dexamethasone tablets and injecti...
22 May, 2021, 06.29 PM IST
Natco Pharma launches anti blood clot medication, Rivaroxaban, in IndiaRivaroxaban is an anticoagulant medication used to treat and prevent blood clots. The medication is currently sold by Bayer under the brand...
17 Dec, 2020, 05.35 PM IST
The week that was: PVR, Dr Reddy's and HCL Tech among 10 names that buzzed during the weekIn the BSE 500 index, 350 stocks closed in the green while the rest ended the week with cuts. Technology, pharma and chemical names topped ...
20 Sep, 2020, 02.24 PM IST
HC Bars Cipla, 3 others from launching generic version of Bristol-Myers’ drugDelhi High Court has granted an injunction restraining the domestic pharma companies such as Cipla, Torrent, Emcure, Alkem from selling a m...
10 Jan, 2020, 11.24 AM IST